Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism

• Autorzy: Jastrzebska M. , Lisman D. , Szelepajlo A. , Oledzki S. , Chelstowski K. , Clark J.S. , Siennicka A.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

antiplatelet therapy; patient; acetylsalicylic acid; coronary heart disease; diabetes mellitus type 2; clopidogrel; aspirin; fibrinogen; glycoprotein; gene polymorphism; platelet aggregation; thromboxane B2

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2019
• Tom: 70
• Numer: 2
• Opis fizyczny: p.175-185,fig.,ref.

Twórcy

autor

Jastrzebska M.

• Department of Laboratory Diagnostics, Pomeranian Medical University, Szczecin, Poland

autor

Lisman D.

• Department of Laboratory Diagnostics, Pomeranian Medical University, Szczecin, Poland

autor

Szelepajlo A.

• Department of Laboratory Diagnostics, Pomeranian Medical University, Szczecin, Poland

autor

Oledzki S.

• Department of Cardiology, Pomeranian Medical University, Szczecin, Poland

autor

Chelstowski K.

• Department of Laboratory Diagnostics, Pomeranian Medical University, Szczecin, Poland

autor

Clark J.S.

• Department of Laboratory Diagnostics, Pomeranian Medical University, Szczecin, Poland

autor

Siennicka A.

• Department of Laboratory Diagnostics, Pomeranian Medical University, 72 Powstancow Wielkopolskich Av., 70-111 Szczecin, Poland

Identyfikatory

DOI

10.26402/jpp.2019.2.01